DE69327307D1 - Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit - Google Patents
Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheitInfo
- Publication number
- DE69327307D1 DE69327307D1 DE69327307T DE69327307T DE69327307D1 DE 69327307 D1 DE69327307 D1 DE 69327307D1 DE 69327307 T DE69327307 T DE 69327307T DE 69327307 T DE69327307 T DE 69327307T DE 69327307 D1 DE69327307 D1 DE 69327307D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccines
- antigens
- disease
- acquired
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9200294A FR2686097B1 (fr) | 1992-01-14 | 1992-01-14 | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
PCT/FR1993/000026 WO1993014196A1 (fr) | 1992-01-14 | 1993-01-13 | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69327307D1 true DE69327307D1 (de) | 2000-01-20 |
DE69327307T2 DE69327307T2 (de) | 2000-08-10 |
Family
ID=9425593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1993627307 Expired - Lifetime DE69327307T2 (de) | 1992-01-14 | 1993-01-13 | Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit |
Country Status (9)
Country | Link |
---|---|
US (1) | US5597721A (de) |
EP (1) | EP0623167B1 (de) |
JP (1) | JPH07505049A (de) |
CA (1) | CA2127991A1 (de) |
DE (1) | DE69327307T2 (de) |
ES (1) | ES2142874T3 (de) |
FR (1) | FR2686097B1 (de) |
PT (1) | PT623167E (de) |
WO (1) | WO1993014196A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU218431B (hu) * | 1991-06-06 | 2000-08-28 | Stichting Centraal Diergeneeskundig Instituut | A rejtélyes sertésvészt okozó Lelystad-vírus, a vírusból származtatható polipeptidek, antigének és nukleinsavak és rejtélyes sertésvész elleni vakcinakészítmények |
US5846805A (en) | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
US6982160B2 (en) * | 1991-08-26 | 2006-01-03 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions that include SIRS virus |
US6080570A (en) * | 1991-08-26 | 2000-06-27 | Boehringer Ingelheim Vetmedica, Inc. | Method of producing a vaccine for Swine Infertility and Respiratory Syndrome |
US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6592873B1 (en) * | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6380376B1 (en) * | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6773908B1 (en) | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
ES2074950B1 (es) * | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
DK0732340T3 (da) * | 1995-03-14 | 2004-10-25 | Akzo Nobel Nv | Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle |
US5866401A (en) * | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
ZA971663B (en) * | 1996-03-01 | 1997-08-26 | Schering Corp | Porcine reproductive and respiratory syndrome vaccine. |
EP0839912A1 (de) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren |
WO2000053787A1 (en) * | 1999-03-08 | 2000-09-14 | Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. | Prrsv vaccines |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
NZ513289A (en) | 1998-12-22 | 2003-04-29 | Pfizer Prod Inc | Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
WO2000065032A1 (en) * | 1999-04-22 | 2000-11-02 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
WO2005121372A2 (en) * | 2004-06-03 | 2005-12-22 | Isis Pharmaceuticals, Inc. | Double strand compositions comprising differentially modified strands for use in gene modulation |
US7611717B2 (en) | 2004-06-18 | 2009-11-03 | Regents Of The University Of Minnesota | Identifying virally infected and vaccinated organisms |
US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
UA95778C2 (ru) | 2005-06-24 | 2011-09-12 | Риджентс Оф Зе Юниверсити Оф Миннесота | Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения |
RU2561595C2 (ru) * | 2008-08-25 | 2015-08-27 | Бёрингер Ингельхайм Ветмедика, Инк. | Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) |
AR078253A1 (es) * | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
SG184833A1 (en) | 2010-04-14 | 2012-11-29 | Emd Millipore Corp | Methods of producing high titer, high purity virus stocks and methods of use thereof |
EA031432B1 (ru) | 2011-02-17 | 2019-01-31 | Бёрингер Ингельхайм Ветмедика Гмбх | Способ получения вируса репродуктивно-респираторного сидрома свиней prrs |
EA038012B1 (ru) | 2011-02-17 | 2021-06-23 | Бёрингер Ингельхайм Ветмедика Гмбх | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
EP2737059A1 (de) | 2011-07-29 | 2014-06-04 | Boehringer Ingelheim Vetmedica GmbH | Neuartiges prrs-virus zur induktion von interferon des typs i in empfindlichen zellen |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9149518B2 (en) | 2012-12-07 | 2015-10-06 | The Board Of Trustees Of The University Of Illinois | Porcine reproductive and respiratory syndrome virus compositions and uses thereof |
CN105073130A (zh) | 2013-03-15 | 2015-11-18 | 勃林格殷格翰动物保健公司 | 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法 |
EA039060B1 (ru) | 2013-12-20 | 2021-11-29 | Бёрингер Ингельхайм Ветмедика Гмбх | Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5052224A (de) * | 1973-09-10 | 1975-05-09 | ||
US4070453A (en) * | 1976-06-25 | 1978-01-24 | Syntex (U.S.A.) Inc. | Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines |
DD145705A1 (de) * | 1979-08-31 | 1981-01-07 | Peter Solisch | Herstellungsverfahren von organspezifischen retrovirusimmunpraeparaten fuer prophylaxe,therapie und diagnostik |
JPS5879929A (ja) * | 1981-11-05 | 1983-05-13 | Biseibutsu Kagaku Kenkyusho:Kk | 日本脳炎・豚パルポ混合ワクチン |
IL70704A0 (en) * | 1983-01-19 | 1984-04-30 | Amgen | Methods and materials for development of parvovirus vaccines |
JPS62198626A (ja) * | 1986-02-26 | 1987-09-02 | Biseibutsu Kagaku Kenkyusho:Kk | 血球凝集性脳脊髄炎ウイルス感染症予防ワクチン |
SU1604851A1 (ru) * | 1988-12-20 | 1990-11-07 | Украинский научно-исследовательский институт сельскохозяйственной микробиологии | Штамм ЕNтеRоVIRUSSUIS дл диагностики энтеровирусной пневмонии свиней |
MX9204885A (es) * | 1991-08-26 | 1994-05-31 | Boehringer Animal Health Inc | Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos. |
FR2682966B1 (fr) * | 1991-10-29 | 1994-12-02 | Rhone Merieux | Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
-
1992
- 1992-01-14 FR FR9200294A patent/FR2686097B1/fr not_active Expired - Lifetime
-
1993
- 1993-01-13 WO PCT/FR1993/000026 patent/WO1993014196A1/fr active IP Right Grant
- 1993-01-13 US US08/256,539 patent/US5597721A/en not_active Expired - Fee Related
- 1993-01-13 ES ES93914480T patent/ES2142874T3/es not_active Expired - Lifetime
- 1993-01-13 JP JP5512195A patent/JPH07505049A/ja active Pending
- 1993-01-13 PT PT93914480T patent/PT623167E/pt unknown
- 1993-01-13 CA CA 2127991 patent/CA2127991A1/en not_active Abandoned
- 1993-01-13 DE DE1993627307 patent/DE69327307T2/de not_active Expired - Lifetime
- 1993-01-13 EP EP93914480A patent/EP0623167B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0623167A1 (de) | 1994-11-09 |
FR2686097B1 (fr) | 1994-12-30 |
WO1993014196A1 (fr) | 1993-07-22 |
EP0623167B1 (de) | 1999-12-15 |
FR2686097A1 (fr) | 1993-07-16 |
DE69327307T2 (de) | 2000-08-10 |
ES2142874T3 (es) | 2000-05-01 |
PT623167E (pt) | 2000-05-31 |
CA2127991A1 (en) | 1993-07-22 |
US5597721A (en) | 1997-01-28 |
JPH07505049A (ja) | 1995-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69327307D1 (de) | Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit | |
DE3789399D1 (de) | Herstellung von Vakkzinen gegen Hepatitis B-Virus. | |
DE69334141D1 (de) | Schweinevirus, Erreger der sich vermehrenden Erkrankung der Atemwege, Impstoffe und seine virale DNA | |
DE69229254D1 (de) | Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper | |
DE68925446D1 (de) | Reagenzien zur Herstellung von 5'-markierten Oligonukleotiden | |
DE69227532T2 (de) | Entwickler zur Entwicklung elektrostatischer Abbildungen, Bilderzeugungsverfahren und Wärmefixierverfahren | |
DE69835031D1 (de) | Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids | |
ATE108067T1 (de) | Impfstoff und verfahren zur herstellung. | |
DE3853341D1 (de) | Form zur verzögerten Diltiazemfreisetzung sowie das daraus hergestellte Arzneimittel. | |
DE3872754D1 (de) | Nachweis von antikoerpern humaner immundefizienz-viren. | |
ATE74487T1 (de) | Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen. | |
DE69010317T3 (de) | Acrylgel und seine Herstellung. | |
DE69400342D1 (de) | Verfahren zur Herstellung von 1,1,1,2-Tetrafluor-2-Chlorethan und Pentafluorethan | |
HU901571D0 (en) | Vaccine and diagnostics against the virus of pig-cholera | |
IT8848638A0 (it) | Peptidi contenenti silicio, loro preparazione e loro impiego come medicamenti | |
DE59108713D1 (de) | Verfahren zur Herstellung von Organopolysiloxanhydrosolen | |
DE59103040D1 (de) | Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen. | |
Mitamura | Epidemiology of HDV infection in Japan | |
DE69428610D1 (de) | Methoden zur kultivierung von infektiösem laryngotracheitis virus und von "egg-drop-syndrome" verursachendem virus | |
DE69007028D1 (de) | Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür. | |
DE69008488D1 (de) | Verfahren zur Herstellung von N-Alkylaminophenolen und von N,N-Dialkylaminophenolen. | |
DE68915694D1 (de) | Verfahren zur Herstellung von verzweigten 1,3-Glykolen und ihren Monoestern. | |
DE59203788D1 (de) | Verfahren zur Herstellung und Reinigung von 1-Amino-2-phenoxy-4-hydroxy-anthrachinon. | |
DE59305709D1 (de) | Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril | |
IT1230175B (it) | Diffusore di vapori profumati e medicali, realizzato mediante l'uso di elementi costruiti in metallo, preferibilmente inossidabile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8365 | Fully valid after opposition proceedings | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN |
|
R071 | Expiry of right |
Ref document number: 623167 Country of ref document: EP |